Pharmafile Logo
Pharmafocus logo
Advanced Search

US Court blocks Novartis biosimilar Neupogen

May 8, 2015
Sales and Marketing Neupogen, Novartis, Zarxio, biosimilar, filagrastim, filgrastim-sndz

Novartis have been temporarily prevented from marketing its biosimilar version of Amgen’s drug Neupogen in the US. Earlier this year …

News
Vaccine image

New malaria vaccine found effective in adults

May 8, 2015
Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …

News
GSk image

Boardroom shuffles at GSK and Roche

May 8, 2015
Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership

GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …

News
app image

New app can aid tropical disease treatment

May 8, 2015
Medical Communications, Sales and Marketing Merck, app, smartphone, tropical diseases

A new smartphone app is able to automatically detect parasites in the blood and may mark a fundamental shift in …

News
tom_richards

Havas Lynx Group hires three

May 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HAVAS LYNX, bainton, linscott, richards

Havas Lynx Group has just bolstered its ranks with the arrival of three new senior appointments. Jon Linscott joins Tim …

Appointment
gilead image

Gilead buys EpiTherapeutics for $65 million

May 7, 2015
Sales and Marketing EpiTherapeutics, Gilead

Gilead is clearly eyeing a future market involving epigenetics as the US firm buys Danish company EpiTherapeutics for $65 million. …

News
J&J image

J&J hands over compassionate use reviews to academics

May 7, 2015
Sales and Marketing J&J, JJ, academics, compac, eap, johnson

Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …

News

Alexion makes $8.4 billion Synageva purchase

May 7, 2015
Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …

News
Pfizer image

Pfizer names new R&D leaders

May 7, 2015
Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat

Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …

News
Chiesi image

Chiesi rapped for ABPI code breach

May 7, 2015
Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA

Chiesi made its sales reps go through a ‘tick-box’ compliance training exercise to get the pharma industry regulator ‘off its …

News
michael_zaiac

Celgene appoints European haematology and oncology head

May 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Michael Zaiac

Swiss-based Celgene International Sàrl has appointed Michael Zaiac to the position of vice president of medical affairs for its European haematology …

Appointment
GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

News
screen_shot_2015-05-06_at_15

ABPI appoints head of medical affairs from GSK

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha

The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …

Appointment
screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …

Appointment
Teva image

Teva forges ahead with Mylan pursuit

May 6, 2015
Sales and Marketing Mylan, Perrigo, Teva, generics

Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …

News
GSK image

GSK files ultra-rare disease application with EMA

May 6, 2015
Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy

GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …

News
Humira image

AbbVie’s Humira meets endpoint in eye disease study

May 6, 2015
Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis

In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …

News
sarret

New chief business officer for Corium

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium

Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer. 

Appointment
china_flag

Chinese government to lift drug price controls

May 5, 2015
Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government

The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …

News
bayer_chimney

Bayer buys blood-thinning drug from Isis

May 5, 2015
Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026